BostonSight expands clinical trials capabilities for optometric and ophthalmic research

Published on August 14, 2025
With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.
Continue reading on website
Other news

NICE approves idebenone for treatment of Leber’s hereditary optic neuropathy

August 14, 2025
The announcement is the first time a treatment for a mitochondrial disease has been approved for use on the NHS in England

Dental and vision services for veterans in Medicare Advantage under the microscope

August 14, 2025
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.